spacer spacer
spacer  
 

Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a complex cardiac disease marked by thickening of the heart muscle. In HCM patients this thickening occurs for no apparent clinical cause like significant high blood pressure. The disease doesn't affect everyone the same way, with different degrees of muscular wall thickening and a variety of symptoms. Patients may have shortness of breath, exercise intolerance, chest pressure or pain, fainting, or no symptoms at all. In unusual cases HCM can cause sudden cardiac death. (read more)

Treating HCM

All patients with hypertrophic cardiomyopathy (HCM) have five aspects of care addressed. We attempt to detect the presence or absence of risk factors for sudden arrhythmic death. If the patient appears to be at high risk, we discuss the benefits and risks of ICD and many patients will be implanted. Symptoms are appraised and may be treated through medicine, surgery, or alcohol ablation. Patients are advised to avoid athletic competition and extremes of physical exertion. First degree family members should be screened with echocardiography and ECG, or genetic testing. Finally if the patient has a high cholesterol level, we advise diets and prescribe cholesterol reducing medication as needed.

Our Doctors

Recently published review article:
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy

Program Brochure: HCM Symposium December 2011

Consultation Office for New York, New Jersey, and Connecticut:
University Medical Practice Associates
425 West 59th Street, Suite 9C
New York, NY 10019
Telephone (212) 492-5550
Fax (212) 492 5555

Back to Genetic Heart Disease


 

 
gipoco.com is neither affiliated with the authors of this page nor responsible for its contents. This is a safe-cache copy of the original web site.